SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-004348
Filing Date
2014-04-29
Accepted
2014-04-29 16:14:10
Documents
5
Period of Report
2014-06-11
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219959zdef14a.htm DEF 14A 439845
2 G367710.JPG g367710.jpg GRAPHIC 8583
3 G627076.JPG g627076.jpg GRAPHIC 107598
4 G113682BCI001.GIF g113682bci001.gif GRAPHIC 65072
5 G113682BCI002.GIF g113682bci002.gif GRAPHIC 69916
  Complete submission text file 0001047469-14-004348.txt   787649
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35119 | Film No.: 14794046
SIC: 2834 Pharmaceutical Preparations